Imatinib increases oxygen delivery in extracellular matrix-rich but not in matrix-poor experimental carcinoma.

J Transl Med · 2017 · PMC5324310 · PMID 28231806

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the CT-26 carcinomas the pO 2 levels also increased after treatment with imatinib although this increase did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.